| ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "M"
Results 131 - 140 of 604 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| MCF-7, acquired resistance T D Bradshaw, M-S Chua, S Orr, C S Matthews and M F G Stevens Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445) doi:10.1054/bjoc.2000.1231 Abstract | Full article | PDF |
||||||||
| MCF-7ras M Di Benedetto, Y Kourbali, A Starzec, R Vassy, J Jozefonvicz, G Perret, M Crepin and M Kraemer Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice doi:10.1054/bjoc.2001.1993 Abstract | Full article | PDF |
||||||||
| MCF7 human breast carcinoma
cell line T Muzzammil, M J Moore, D Hedley and J R Ballinger Comparison of 99mTc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function doi:10.1054/bjoc.2000.1621 Abstract | Full article | PDF |
||||||||
| Mcl-1 M M Borner, P Brousset, B Pfanner-Meyer, M Bacchi, S Vonlanthen, D Schlaifer and D C Betticher Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer doi:10.1038/sj.bjc.6690152 Abstract | Full article | PDF |
||||||||
| MCM A Shetty, M Loddo, T Fanshawe, A T Prevost, R Sainsbury, G H Williams and K Stoeber DNA replication licensing and cell cycle kinetics of normal and neoplastic breast advance online publication, 2005-11-08 00:00:00.000; doi:10.1038/sj.bjc.6602829 Abstract | Full article | PDF L Ayaru, K Stoeber, G J Webster, A R W Hatfield, A Wollenschlaeger, O Okoturo, M Rashid, G Williams and S P Pereira Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates advance online publication, 2008-04-15 00:00:00.000; doi:10.1038/sj.bjc.6604342 Abstract | Full article | PDF |
||||||||
| MCM2 A Shetty, M Loddo, T Fanshawe, A T Prevost, R Sainsbury, G H Williams and K Stoeber DNA replication licensing and cell cycle kinetics of normal and neoplastic breast advance online publication, 2005-11-08 00:00:00.000; doi:10.1038/sj.bjc.6602829 Abstract | Full article | PDF T J Dudderidge, S R McCracken, M Loddo, T R Fanshawe, J D Kelly, D E Neal, H Y Leung, G H Williams and K Stoeber Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer advance online publication, 2007-04-03 00:00:00.000; doi:10.1038/sj.bjc.6603718 Abstract | Full article | PDF M Burger, S Denzinger, A Hartmann, W-F Wieland, R Stoehr and E C Obermann Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade advance online publication, 2007-05-15 00:00:00.000; doi:10.1038/sj.bjc.6603784 Abstract | Full article | PDF |
||||||||
| MCP-1 J M Arnold, P R Huggard, M Cummings, G A Ramm and G Chenevix-Trench Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma advance online publication, 2005-05-17 00:00:00.000; doi:10.1038/sj.bjc.6602596 Abstract | Full article | PDF L Hefler, C Tempfer, G Heinze, K Mayerhofer, G Breitenecker, S Leodolter, A Reinthaller and C Kainz Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients doi:10.1038/sj.bjc.6690776 Abstract | Full article | PDF |
||||||||
| MD-mTHPC H-B Ris, T Krueger, A Giger, C K Lim, J C M Stewart, U Althaus and H J Altermatt Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts doi:10.1038/sj.bjc.6690170 Abstract | Full article | PDF |
||||||||
| MDA-MB-231 cell line B J Allen, Z Tian, S M A Rizvi, Y Li and M Ranson Preclinical studies of targeted  therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2
doi:10.1038/sj.bjc.6600838 Abstract | Full article | PDF |
||||||||
| mdm2 T Schlott, J G Scharf, C Gorzel, P Middel and H Spring Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators doi:10.1038/sj.bjc.6600238 Abstract | Full article | PDF C Klein and L T Vassilev Targeting the p53–MDM2 interaction to treat cancer advance online publication, 2004-09-28 00:00:00.000; doi:10.1038/sj.bjc.6602164 Abstract | Full article | PDF O Larsson, A Girnita and L Girnita Role of insulin-like growth factor 1 receptor signalling in cancer advance online publication, 2005-05-24 00:00:00.000; doi:10.1038/sj.bjc.6602627 Abstract | Full article | PDF D Chen, C L Brooks and W Gu ARF-BP1 as a potential therapeutic target advance online publication, 2006-04-25 00:00:00.000; doi:10.1038/sj.bjc.6603119 Abstract | Full article | PDF C Beskow, L Kanter, Å Holgersson, B Nilsson, B Frankendal, E Åvall-Lundqvist and R Lewensohn Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer advance online publication, 2006-05-09 00:00:00.000; doi:10.1038/sj.bjc.6603153 Abstract | Full article | PDF A G Emanuels, J Koudstaal, M P M Burger and H Hollema In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases doi:10.1038/sj.bjc.6690318 Abstract | Full article | PDF T Schlott, K Ahrens, I Ruschenburg, S Reimer, H Hartmann and M Droese Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia doi:10.1038/sj.bjc.6690324 Abstract | Full article | PDF G Nawa, Y Miyoshi, H Yoshikawa, T Ochi and Y Nakamura Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours doi:10.1038/sj.bjc.6690484 Abstract | Full article | PDF I Ganly, D S Soutar, R Brown and S B Kaye p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy doi:10.1054/bjoc.1999.0932 Abstract | Full article | PDF S Pilotti, G Della Torre, A Mezzelani, E Tamborini, A Azzarelli, G Sozzi and M A Pierotti The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma doi:10.1054/bjoc.1999.1090 Abstract | Full article | PDF J-F Mirjolet, M Barberi-Heyob, C Didelot, J-P Peyrat, J Abecassis, R Millon and J-L Merlin Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status doi:10.1054/bjoc.2000.1455 Abstract | Full article | PDF P Tanière, G Martel-Planche, J C Saurin, C Lombard-Bohas, F Berger, J Y Scoazec and P Hainaut TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe doi:10.1054/bjoc.2001.1990 Abstract | Full article | PDF H A Cocker, S M Hobbs, N Tiffin, K Pritchard-Jones, C R Pinkerton and L R Kelland High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance doi:10.1054/bjoc.2001.2145 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||